R01DK114311

NIH – National Institute of Diabetes and Digestive and Kidney Diseases

Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation

Song, X., Xu, H., Wang, P., Wang, J., Affo, S., Wang, H., Xu, M., Liang, B., Che, L., Qiu, W., Schwabe, R. F., Chang, T. T., Vogl, M., Pes, G. M., Ribback, S., Evert, M., Chen, X., & Calvisi, D. F. (2021). Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation. Journal of Hepatology, 75(4), 888–899. https://doi.org/10.1016/j.jhep.2021.05.018
Authors:
Xinhua Song
Hongwei Xu
Pan Wang
Haichuan Wang
Li Che
Xin Chen
Tammy T. Chang
Jingxiao Wang
Silvia Affo
Robert F. Schwabe
Meng Xu
Binyong Liang
Wei Qiu
Marion Vogl
Matthias Evert
Diego F. Calvisi
Giovanni M. Pes
Silvia Ribback
Affiliated Authors:
Silvia Affo
Robert F. Schwabe
Author Keywords:
intrahepatic cholangiocarcinoma
fak
yap
targeted therapy
cancer
Grants:
R01CA197128 (NIH – National Cancer Institute)
R01CA190606 (NIH – National Cancer Institute)
R03CA208311 (NIH – National Cancer Institute)
R01CA228483 (NIH – National Cancer Institute)
R01DK114311 (NIH – National Institute of Diabetes and Digestive and Kidney Diseases)
P30DK026743 (NIH – National Institute of Diabetes and Digestive and Kidney Diseases)
Publication Type:
Article
Unique ID:
10.1016/j.jhep.2021.05.018
PMID:
Publication Date:
Data Source:
Web of Science

Record Created: